Weidner, N., Abel, R., Maier, D., Röhl, K., Röhrich, F., Baumberger, M., . . . Curt, A. (2025). Safety and efficacy of intrathecal antibodies to Nogo-A in patients with acute cervical spinal cord injury: A randomised, double-blind, multicentre, placebo-controlled, phase 2b trial. The lancet, 24(1), . https://doi.org/10.1016/S1474-4422(24)00447-2
Chicago-Zitierstil (17. Ausg.)Weidner, Norbert, et al. "Safety and Efficacy of Intrathecal Antibodies to Nogo-A in Patients with Acute Cervical Spinal Cord Injury: A Randomised, Double-blind, Multicentre, Placebo-controlled, Phase 2b Trial." The Lancet 24, no. 1 (2025). https://doi.org/10.1016/S1474-4422(24)00447-2.
MLA-Zitierstil (9. Ausg.)Weidner, Norbert, et al. "Safety and Efficacy of Intrathecal Antibodies to Nogo-A in Patients with Acute Cervical Spinal Cord Injury: A Randomised, Double-blind, Multicentre, Placebo-controlled, Phase 2b Trial." The Lancet, vol. 24, no. 1, 2025, https://doi.org/10.1016/S1474-4422(24)00447-2.